Home About us Contact
|
Home About us Contact | ||
|
|
||
Initial Delay (initial + delay)
Selected AbstractsPulsed saturation of the standard two-pool model for magnetization transfer.CONCEPTS IN MAGNETIC RESONANCE, Issue 1 2004Part II: The transition to steady state Abstract The transition of the tissue signal to steady state under periodic selective saturation of macromolecular magnetization can be observed by single-shot echo-planar imaging. The general solution for a two-pool system with linear exchange kinetics contains two transient components. The rapid minor transient causes an initial delay of the transition for fast pulse repetition (PR) and weak saturation. The slow major transient combines progressive direct saturation and transferred saturation. Its PR -dependence provides similar information as the steady state, but is less sensitive to direct saturation and fitting errors. Sampling at different PR allows to quantify all system parameters. © 2004 Wiley Periodicals, Inc. Concepts Magn Reson Part A 21A: 50,62, 2004 [source] Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatmentADDICTION, Issue 9 2009Peter Hajek ABSTRACT Aim While older behavioural and pharmacological approaches to preventing relapse to smoking show little efficacy, a recent randomized trial of an extended course of varenicline reported positive results. In this secondary analysis, trial data were examined to see whether smokers who manage to achieve abstinence only later in the original course of treatment are more likely to benefit from having the course extended. Methods A total of 1208 patients abstinent for at least the last week of 12 weeks' treatment with varenicline were randomized to 3 months continued varenicline or placebo. Overall, 44% of the 12-week abstainers were abstinent from the target quit date (TQD), while the rest stopped smoking later. We examined the relationship between quit pattern and the varenicline versus placebo difference in continuous abstinence rates at week 52 and contributions of baseline patient characteristics. Results With increasing delay in initial quitting, 12-month success rates declined. Participants who had their last cigarette at week 11 of open-label treatment had quit rates at 52 weeks of 5.7% compared with 54.9% in those who last smoked in week 1 [odds ratio (OR) 20.3 (6.3, 65.9); P < 0.0001]. Patients who failed to initiate abstinence in the first week benefited more from extended treatment than patients continuously abstinent from week 1 [OR 1.7 (1.2, 2.4); P = 0.0015 versus OR 1.1 (0.8, 1.5); P = 0.6995, respectively; with the interaction of the quit pattern with treatment effect reaching borderline significance (P = 0.0494)]. No other patient characteristics were related to treatment effect. Conclusions Compared with smokers who quit smoking on their TQD, those who have an initial delay in achieving sustained abstinence have increased risk of relapse even several months later, and may be more likely to benefit from extended treatment with varenicline. [source] Pharmacokinetics of fentanyl delivered transdermally in healthy adult horses , variability among horses and its clinical implicationsJOURNAL OF VETERINARY PHARMACOLOGY & THERAPEUTICS, Issue 6 2006J. A. ORSINI The safety and pharmacokinetics of fentanyl, delivered transdermally at a dosage of 60,67 ,g/kg, were investigated in six healthy adult horses. Three transdermal fentanyl patches (Duragesic®), each containing 10 mg of fentanyl citrate, were applied to the mid-dorsal thorax of each horse and left in place for 72 h. Plasma fentanyl concentrations were periodically measured throughout this period and for 12 h after patch removal. After an initial delay of approximately 2 h, the plasma fentanyl concentration rose rapidly in a fairly linear fashion, reaching a peak at around 12 h; thereafter, it gradually declined in a roughly linear manner over the next 72 h. There was much individual variation, however. The initial delay ranged from 0 to 5.1 h (mean, 1.91 ± 2.0 h), Tcmax ranged from 8.5 to 14.5 h (mean, 11.4 ± 2.7 h) and Cmax ranged from 0.67 to 5.12 ng/mL (mean, 2.77 ± 1.92 ng/mL). In two horses, the plasma fentanyl concentration failed to reach even 1 ng/mL, whereas in the other four horses it was >1 ng/mL for at least 40 h and for at least 72 h in two of these horses. No adverse effects attributable to fentanyl were observed in any of the horses, indicating that this dosage is safe in systemically healthy adult horses. However, it failed to achieve plasma fentanyl concentrations generally considered to be analgesic (,1 ng/mL) in about one-third of horses. [source] Deletion of 8p: a report of a child with normal intelligenceDEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Issue 12 2001Linda Gilmore PhD The case is presented of a female infant with a distal deletion of 8p (8p23.1,pter) whose development was monitored over a 5-year period from 12 months of age. Although previous literature has suggested that 8p deletion is associated with mild to moderate intellectual disability, the child reported here has normal intelligence. Despite initial delays in gross motor and language skills, cognitive development (assessed with the Bayley Scales of Infant Development) and intellectual ability (measured on the Stanford-Binet Intelligence Scale) were within average range. It is argued that the small number of previous case reports may have created a misleading impression of intellectual development in individuals with distal deletions of 8p. [source] | ||||||||||